- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
AJMC® in the Press, January 29, 2021
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
An article by Becker's Spine Review referenced a study published in the October 2020 issue of The American Journal of Managed Care® (AJMC®). The study, “Successes and Failures With Bundled Payments in the Commercial Market,” indicated that while Medicare has embraced condition-specific bundled payments in its Bundled Payments for Care Improvement initiatives, commercial insurers have been slow to follow Medicare’s lead. As the authors note, successful plans have closely aligned providers and payers who share data seamlessly.
A press release by Ken Research cited an article published by AJMC®’s sister site The Center for Biosimilars®, titled “As Patents Expire, Oncology Biosimilars Poised to Expand, Authors Say.” The article noted that by 2023, patents on nearly 20 oncology biologics will expire, which could lead to more biosimilars in cancer care and therefore reduced costs.
A piece by TulsaPeople Magazine spotlighted an article published on AJMC.com, the website of AJMC®. The article, “Cancer Care Delays in COVID-19 Could Lead to Higher Morbidity, Mortality,” indicated that screening and treatments for breast, colon, prostate, and lung cancers saw significant declines in 2020 due to the coronavirus disease 2019 pandemic, with oncology care delivery still yet to fully rebound.
Mitigating Barriers to Cell and Gene Therapy Access
February 14th 2025Cell and gene therapies can be life-changing for patients with certain conditions, but the process of receiving them poses barriers for patients and caregivers that require multistakeholder solutions, according to a white paper from the National Pharmaceutical Council.
Read More
CMS Medicare Final Rule: Advancing Benefits, Competition, and Consumer Protection
May 7th 2024On this episode of Managed Care Cast, we're talking with Karen Iapoce, senior director of government products and programs at ZeOmega, about the recent CMS final rule on Medicare Part D and Medicare Advantage.
Listen
Study Suggests Postdischarge Care Needs Targeted, Multifaceted Approaches
January 15th 2025The findings challenge the effectiveness of these widely used transitional care interventions and suggest a need for more targeted, multifaceted approaches to address the needs of higher-risk patients.
Read More
